ENTRY       D10488                      Drug
NAME        Serelaxin (USAN/INN);
            Serelaxin (genetical recombination) (JAN)
FORMULA     C256H408N74O74S8
EXACT_MASS  5958.8203
MOL_WEIGHT  5962.9501
SEQUENCE    (Heavy chain)
            DSWMEEVIKL CGRELVRAQI AICGMSTWS
            (Light chain)
            QLYSALANKC CHVGCTKRSL ARFC
            (Disulfide bridge: H11-L11, H23-L24, L10-L15)
            (modified residues: L1:Q=L-pyroglutamic acid [CPD:C01879])
  TYPE      Peptide
REMARK      ATC code: C01DX21
EFFICACY    Vasodilator, Relaxin receptor agonist
COMMENT     Recombinant human relaxin-2 [HSA:6019] [KO:K05255]
            Treatment of acute heart failure
TARGET      RXFP1 [HSA:59350] [KO:K04306]
  PATHWAY   hsa04080(59350)  Neuroactive ligand-receptor interaction
            hsa04926(59350)  Relaxin signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01D VASODILATORS USED IN CARDIAC DISEASES
                C01DX Other vasodilators used in cardiac diseases
                 C01DX21 Serelaxin
                  D10488  Serelaxin (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Relaxin
                RXFP1
                 D10488  Serelaxin (USAN/INN)
DBLINKS     CAS: 99489-94-8
            PubChem: 172232581
///
